Conmed Corp (CNMD) 53.40 $CNMD Best Performing Stocks On

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2015 at 10:50 AM

Conmed Corp (CNMD) 53.40 $CNMD

Best Performing Stocks On Earnings
Bespoke Investment Group - at Seeking Alpha - Sun Apr 26, 3:00AM CDT
The average stock that has reported this season has gained 0.71% on its earnings reaction day (the first trading day following its report). Below is a list of the stocks that have done the best on their earnings reaction days. As shown, Travelzoo...
TZOO: 12.89 (-0.14), ASPS: 23.24 (+0.76), SKX: 89.66 (+2.79), SXC: 17.43 (-0.09), HSTM: 31.02 (+0.88), ZEP: 19.88 (-0.03), SQNS: 2.10 (-0.15), TTS: 14.01 (-0.17), GIMO: 29.75 (+6.16), DCO: 32.10 (+1.06), PIR: 13.29 (+0.23), APOG: 53.48 (+0.55), CNMD: 53.40 (-0.83), DPZ: 113.96 (+4.73), PGI: 10.79 (+1.29), TCPI: 3.86 (-0.07), VASC: 35.31 (+0.45), AAN: 32.80 (+3.43), MSFT: 47.87 (+4.53), AMZN: 445.10 (+55.11), HAS: 71.61 (-0.10), ATI: 34.61 (+0.05), ECHO: 32.68 (-1.14), ACTG: 11.10 (+1.08), MDSO: 57.59 (+0.05), CAMP: 20.34 (-1.41), HA: 23.60 (+2.10), RMBS: 13.99 (-0.31), CLB: 124.69 (-0.63), ADPT: 63.78 (+2.13), NFLX: 558.40 (-0.66), TBI: 29.20 (+4.39), RS: 63.14 (+0.45), CE: 65.85 (+0.75), CPHD: 58.97 (+5.67), CLGX: 39.45 (+0.23), WIRE: 45.34 (+3.93), BAS: 8.70 (+0.62), FTNT: 38.68 (-0.04), EHTH: 13.50 (+2.06)

CONMED (CNMD) Shows Strength: Stock Gains 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 8:58AM CDT
CONMED (CNMD) was a big mover last session, with shares rising nearly 10% on the day.
CNMD: 53.40 (-0.83), MMSI: 20.58 (+1.34)

Conmed reports Q1 results
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 10:04AM CDT

CNMD: 53.40 (-0.83)

CONMED (CNMD) Q1 Earnings, Revenues Beat; Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 8:45AM CDT
CONMED Corp (CNMD) posted adjusted earnings of 42 cents per share in the first quarter of 2015, which beat the Zacks Consensus Estimate by a penny but declined 14.2% on a year-over-year basis.
ABC: 115.48 (+0.28), BDX: 144.33 (-0.02), CNMD: 53.40 (-0.83), MMSI: 20.58 (+1.34)

CONMED posts lower GAAP diluted earnings per share of USD0.23 in Q1 2015
M2 - Thu Apr 23, 7:13AM CDT
Medical technology company CONMED (Nasdaq:CNMD) disclosed on Wednesday its GAAP diluted earnings per share of USD0.23 for the first quarter ended 31 March 2015.
CNMD: 53.40 (-0.83)

CONMED (CNMD) Curt R. Hartman on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 8:21PM CDT

CNMD: 53.40 (-0.83)

Conmed posts 1Q profit
Automated Insights - Wed Apr 22, 3:47PM CDT
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Wednesday reported first-quarter earnings of $6.3 million.
CNMD: 53.40 (-0.83)

CONMED (CNMD) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Apr 22, 3:25PM CDT

CNMD: 53.40 (-0.83)

CONMED misses by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 3:03PM CDT

CNMD: 53.40 (-0.83)

CONMED Corporation Announces First Quarter 2015 Financial Results
Business Wire - Wed Apr 22, 3:01PM CDT
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the first quarter ended March 31, 2015.
CNMD: 53.40 (-0.83)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 4:35PM CDT

SKX: 89.66 (+2.79), SLG: 128.82 (+1.47), AMP: 127.75 (+0.58), CTXS: 66.99 (-0.35), WSTC: 32.20 (-0.01), SLM: 10.25 (+0.02), CAKE: 52.98 (+0.56), WFT: 14.16 (-0.05), TYL: 132.12 (+1.82), FFIV: 123.18 (+0.78), LOGI: 15.01 (-0.47), MKSI: 35.94 (+0.44), FTK: 14.06 (-0.43), AHL: 47.77 (-0.09), TMK: 56.09 (-0.11), HNI: 51.98 (+0.71), FOE: 12.62 (unch), FB: 81.53 (-0.88), PLCM: 12.94 (-0.15), CLB: 124.69 (-0.63), XLNX: 42.88 (-0.88), RJF: 57.06 (-0.50), TXN: 54.73 (+0.01), AF: 13.05 (-0.06), VMI: 124.44 (+1.30), CCI: 85.98 (-0.66), OII: 54.10 (-1.47), CLW: 64.38 (+0.21), AFOP: 19.33 (-0.43), SGMO: 14.70 (-0.84), LVS: 55.25 (+0.13), AWH: 41.69 (-0.02), TSCO: 90.98 (-0.28), USTR: 42.07 (-0.28), CVA: 20.97 (-0.40), T: 34.01 (-0.22), EBAY: 59.20 (+0.31), IBKC: 62.86 (-0.61), CNMD: 53.40 (-0.83), QCOM: 68.24 (-0.10), PLXS: 44.20 (-0.32), BDN: 15.00 (+0.35), SUSQ: 13.40 (-0.01), NEU: 461.52 (-7.91), GGG: 71.11 (-1.09), ORLY: 229.35 (+1.04), CYS: 9.15 (+0.05), LHO: 38.40 (-0.10), EFX: 98.49 (+0.09), CUB: 50.07 (-0.15), ALGT: 168.12 (+1.10), TCBI: 51.61 (-0.61), SCSS: 34.50 (+0.86), CLGX: 39.45 (+0.23), IGT: 20.21 (+0.21)

Will CONMED (CNMD) Disappoint Earnings Estimates in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 12:30PM CDT
Our proven model does not conclusively show that CONMED Corp. (CNMD) is likely to beat earnings this quarter as it does not have the right combination of two key ingredients.
BIIB: 401.71 (-28.57), CNMD: 53.40 (-0.83), MRTX: 27.87 (-0.15), MEIP: 2.16 (-0.02)

CONMED Corporation to Present at Two Investor Conferences in May
Business Wire - Mon Apr 20, 7:00AM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, will present at the following two investor conferences in May.
CNMD: 53.40 (-0.83), DB: 34.26 (+0.11)

Conmed Has Returned 18.8% Since SmarTrend Recommendation (CNMD)
Comtex SmarTrend(R) - Thu Apr 09, 10:05AM CDT
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on October 27th, 2014 at $41.77. In approximately 5 months, Conmed has returned 18.82% as of today's recent price of $49.63.
CNMD: 53.40 (-0.83)

CONMED Corporation to Announce First Quarter 2015 Financial Results on April 22, 2015
Business Wire - Tue Apr 07, 3:06PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the first quarter of fiscal year 2015 after the market close on Wednesday, April 22, 2015. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CNMD: 53.40 (-0.83)

Insider Trading Alert - CNMD, DST And HTWR Traded By Insiders
at The Street - Mon Apr 06, 11:07AM CDT
Stocks with insider trader activity include CNMD, DST and HTWR
CNMD: 53.40 (-0.83), HTWR: 78.80 (-0.82), DST: 118.00 (+0.99)

The Best Small Cap Stocks To Buy Now
Todd Campbell - at Seeking Alpha - Mon Apr 06, 4:40AM CDT

PMC: 30.50 (-0.29), MATW: 50.80 (-0.20), ELLI: 57.75 (+0.69), SILC: 44.20 (+1.71), SGMO: 14.70 (-0.84), AFFX: 12.44 (-0.16), BABY: 42.15 (-0.01), HBIO: 6.22 (+0.08), EXAM: 43.13 (-0.04), IART: 61.31 (+0.84), SNCR: 51.48 (-0.44), CNMD: 53.40 (-0.83), BJRI: 49.52 (-3.92), NLNK: 52.10 (-0.90), CTRN: 24.69 (+0.29), ANAC: 64.49 (-2.10), PRSC: 49.35 (+0.02), RRGB: 83.32 (+1.41), ALOG: 88.06 (-0.13), DIOD: 27.28 (-0.72), LGND: 89.75 (+0.83), DEPO: 27.65 (+0.36), ASTE: 43.09 (+0.01), DYAX: 27.44 (-0.85), FARO: 43.44 (-1.22), ECOL: 49.43 (+0.31), PFPT: 54.33 (-2.60), MTSI: 31.41 (-1.92), IRWD: 15.10 (-0.38), ABAX: 63.62 (+0.31), ANIP: 70.26 (-1.52), FORM: 9.16 (-0.13), QLGC: 15.26 (+0.07), ADUS: 28.86 (+0.41), SNHY: 41.42 (+0.11), EBIX: 29.77 (-0.21), SWHC: 15.01 (+0.10)

Conmed Up 24.0% Since SmarTrend Uptrend Call (CNMD)
Comtex SmarTrend(R) - Thu Apr 02, 10:07AM CDT
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on October 27th, 2014 at $41.77. In approximately 5 months, Conmed has returned 24.01% as of today's recent price of $51.80.
CNMD: 53.40 (-0.83)

CONMED Corporation to Present at the 14th Annual Needham Healthcare Conference
Business Wire - Wed Apr 01, 7:00AM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference at 11:20 a.m. ET on Tuesday, April 14, 2015 in New York, NY.
CNMD: 53.40 (-0.83)

Conmed Shares Up 19.5% Since SmarTrend's Buy Recommendation (CNMD)
Comtex SmarTrend(R) - Wed Mar 25, 4:52PM CDT
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on October 27th, 2014 at $41.77. In approximately 5 months, Conmed has returned 19.46% as of today's recent price of $49.90.
CNMD: 53.40 (-0.83)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Patriot Growth Welcomes Rajeev Jain: Operational Excellence

Shifting Gears: Patriot Growth's New Leadership Turn When it comes to tightening the ship and pointing towards uncharted waters, new leadership can be the key. This couldn't be more true for Patriot Growth Insurance Services as they welcome Rajeev Jain aboard as their latest Chief Operating Officer. This move is all about reinforcing their commitment to operational...

Philanthropy in Focus: Town & Country's Star-Studded Day

An Annual Celebration of Generosity Town & Country, marking 180 years of observing the social highs and lows, just wrapped up its 13th Annual Philanthropy Summit at Hearst Tower. This wasn't your run-of-the-mill event where you sit and awkwardly sip bad coffee. When you've got high-profile names like Tory Burch and Russell Wilson in the same room, you know it’s a...

Multiplier's Data Signals Global Hiring Evolution

Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...

Microplastics Found in Human Blood: Alarming Evidence

An Unsettling Discovery in Our Veins Microplastics in the blood? Yep, you read that right, and it’s not some sci-fi horror story—it’s today’s harsh reality. A riveting report from the likes of the Plastic Pollution Coalition and the Canadian Association of Physicians for the Environment has thrown a bucket of cold water on us. They uncovered microplastics in 96%...

Greek-Serbian Heads Meet to Prep for 2027 Tourism Expo

Breaking Cultural and Business Barriers You ever get that feeling when two neighbors finally decide to have a proper sit-down and hash things out? That's the vibe in Athens today, as Greek and Serbian movers and shakers are gathering to lay the groundwork for EXPO 2027 Belgrade. It's a match that's kinda hard to ignore if you're watching Europe's trade routes—especially...

Northern.tech Enhances Product Software Control & Security

The Evolution of Product Software Management Over in Palo Alto, Northern.tech has just flipped the switch on something pretty significant—component orchestration in their Mender solution. This isn't just your run-of-the-mill software update. They're talking about managing software across the entire system of a connected product. You know, pulling all the strings at...

Radius Global Rebrands to Unite Infrastructure Investments

Changing Gears to Navigate Global Connectivity Alright, buckle up because Radius Global Infrastructure, Inc. is making a move that’ll reshape how they play the digital infrastructure game. As of October 28, 2026, they’ve wrapped APWireless into their fold, waving goodbye to separate identities and hello to a unified brand. If you’ve got a finger in the tech pie,...

CELSET Unveils SOLTOX: Expanding in Global Markets

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

New Ambulatory Surgery Center in Alabama Breaks Ground

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Beta Bionics Lawsuit: What Investors Need to Know

Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...